Trial tests new combo for Tough-to-Treat cancers
NCT ID NCT04284488
Summary
This study tested the safety and effectiveness of combining two drugs, APG-1387 and toripalimab, for people with advanced solid tumors that had stopped responding to standard treatments. The trial involved about 40 participants with specific cancers, including colorectal cancer, nasopharyngeal carcinoma, and non-small cell lung cancer. The goal was to find the best dose and see if the combination could help control the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Foshan First People's Hospital
Foshan, Guangdong, China
-
Sun-Yat Sen University Cancer Center
Guangzhou, Guangdong, 510060, China
-
The Affiliated Hospital OF Guangxi Medical University
Nanning, Guangxi, 530021, China
Conditions
Explore the condition pages connected to this study.